On February 21, 2023 Accuray Incorporated (NASDAQ: ARAY) reported its participation in the Cowen 43rd Annual Health Care Conference taking place March 6-8, 2022 (Press release, Accuray, FEB 21, 2023, View Source [SID1234627480]). The management team is scheduled to participate in a Fireside Chat on Monday, March 6, 2023 at 10:30am PST / 1:30pm EST.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the Fireside Chat can be accessed on the Accuray website at investors.accuray.com. A replay will be available on the company’s website following the event.

On February 21, 2023 Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) reported that management will present at Cowen’s 43rd Annual Health Care Conference on Tuesday, March 7, 2023 at 2:50 p.m. ET (Press release, Vertex Pharmaceuticals, FEB 21, 2023, https://investors.vrtx.com/news-releases/news-release-details/vertex-present-cowens-43rd-annual-health-care-conference-march-7 [SID1234627479]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of management’s remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company’s website.

On February 21, 2023 Mirati Therapeutics, Inc. (NASDAQ: MRTX), a targeted oncology company, reported that it will participate at the 43rd Annual Cowen Health Care Conference on March 6 at 11:10 a.m. P.T. / 2:10 p.m. E.T. David Meek, chief executive officer, will represent the company in a fireside chat (Press release, , FEB 21, 2023, View Source [SID1234627478]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investors and the general public are invited to listen to a live webcast of the session through the "Investors and Media" section on Mirati.com. A replay of the webcast will be made available following the event.

On February 21, 2023 Novavax, Inc. (Nasdaq: NVAX), a global vaccines company advancing protein-based vaccines with its novel Matrix-M adjuvant, reported it will report its fourth quarter and full year 2022 financial results and operational highlights on Tuesday, February 28, 2023, following the close of U.S. financial markets (Press release, Novavax, FEB 21, 2023, View Source,-2023 [SID1234627477]). Details of the event and replay are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference call details:

Date:

February 28, 2023

Time:

4:30 p.m. U.S. Eastern Standard Time (EST)

Dial-in number:

(833) 974-2381 (Domestic) or (412) 317-5774 (International)

Webcast:

ir.novavax.com/events

Participants will be prompted to request to join the Novavax, Inc. call.
To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled webcast.
Replay details:

Date:

Available starting at 7:30 p.m. EST, February 28, 2023 until 11:59 p.m. U.S. EST, March 7, 2023

Dial-in number:

(877) 344-7529 (Domestic) or (412) 317-0088 (International)

Passcode:

1137418

Webcast:

ir.novavax.com/events, until May 28, 2023

On February 21, 2023 Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, reported that the company is scheduled to hold a conference call on Wednesday, February 22, 2023 at 4:30 p.m. ET to review its fourth quarter and full year 2022 financial results and business updates (Press release, Sangamo Therapeutics, FEB 21, 2023, View Source [SID1234627476]). Prior to the call, the company will have released its fourth quarter and full year financial results.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Participants should register for, and access, the call using this link. While not required, it is recommended to join 10 minutes prior to the event start. Once registered, participants will be given the option to either dial into the call with the number and unique passcode provided, or to use the dial-out option to connect their phone instantly. The link to access the live webcast can also be found on the Sangamo Therapeutics website in the Investors and Media section under Events.

An updated corporate presentation will be available in the Investors and Media section under Presentations.

A replay will be available following the conference call, accessible under Events.